FEDERTI, Enrica
 Distribuzione geografica
Continente #
NA - Nord America 1.709
EU - Europa 1.653
AS - Asia 1.487
SA - Sud America 215
Continente sconosciuto - Info sul continente non disponibili 70
AF - Africa 49
OC - Oceania 5
Totale 5.188
Nazione #
US - Stati Uniti d'America 1.661
RU - Federazione Russa 803
SG - Singapore 552
CN - Cina 327
IT - Italia 196
GB - Regno Unito 189
VN - Vietnam 176
BR - Brasile 173
HK - Hong Kong 172
DE - Germania 95
SE - Svezia 83
FR - Francia 76
IE - Irlanda 72
BD - Bangladesh 50
FI - Finlandia 46
KR - Corea 42
JP - Giappone 33
CA - Canada 30
ID - Indonesia 27
IN - India 27
AT - Austria 20
AR - Argentina 19
UA - Ucraina 16
MX - Messico 14
NL - Olanda 11
TR - Turchia 11
NG - Nigeria 10
TW - Taiwan 10
PL - Polonia 9
EG - Egitto 8
ES - Italia 8
IQ - Iraq 8
MY - Malesia 8
PK - Pakistan 8
CO - Colombia 7
TG - Togo 7
ZA - Sudafrica 7
BE - Belgio 6
BJ - Benin 6
CL - Cile 6
IR - Iran 5
LT - Lituania 5
MA - Marocco 5
AU - Australia 4
JO - Giordania 4
LB - Libano 4
NP - Nepal 4
PH - Filippine 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
GR - Grecia 3
UZ - Uzbekistan 3
VE - Venezuela 3
DZ - Algeria 2
HU - Ungheria 2
KE - Kenya 2
KZ - Kazakistan 2
OM - Oman 2
PY - Paraguay 2
SA - Arabia Saudita 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BB - Barbados 1
BT - Bhutan 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GH - Ghana 1
KG - Kirghizistan 1
KH - Cambogia 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
UY - Uruguay 1
Totale 5.119
Città #
Moscow 311
Singapore 285
Ashburn 257
San Jose 188
Hong Kong 169
Chandler 157
Southend 134
Dallas 130
Dublin 72
Verona 65
Beijing 63
Council Bluffs 61
Jacksonville 45
Ho Chi Minh City 44
The Dalles 42
Los Angeles 34
Ann Arbor 33
New York 33
Wilmington 32
Tokyo 31
Dong Ket 30
Hanoi 28
Munich 27
Jakarta 24
Helsinki 23
Houston 23
Lawrence 23
Princeton 22
Milan 19
Redondo Beach 16
Seattle 16
São Paulo 16
Jinan 14
Rome 14
Santa Clara 14
Buffalo 13
Nanjing 13
Sindelfingen 13
Vienna 13
London 12
Blacksburg 11
Hebei 11
Nuremberg 11
Redmond 11
Columbus 10
Frankfurt am Main 10
Guangzhou 10
Montreal 10
Orem 10
Turku 10
Collegeville 9
Falls Church 9
Warsaw 9
West Lafayette 9
Atlanta 8
Campinas 8
Tianjin 8
Zhengzhou 8
Abuja 7
Belo Horizonte 7
Boardman 7
Bologna 7
Haiphong 7
Lappeenranta 7
Lomé 7
Nanchang 7
San Francisco 7
Toronto 7
Woodbridge 7
Chennai 6
City of London 6
Cotonou 6
Da Nang 6
Hangzhou 6
Ningbo 6
Shanghai 6
Shenyang 6
Baghdad 5
Brussels 5
Cambridge 5
Changsha 5
Chicago 5
Cincinnati 5
Dongguan 5
Memphis 5
Perryville 5
Tacoma 5
Washington 5
Xi'an 5
Amman 4
Boston 4
Brooklyn 4
Cagliari 4
Chieti 4
Chions 4
Denver 4
Detroit 4
Fairfield 4
Kuala Lumpur 4
Manchester 4
Totale 2.960
Nome #
Impaired pro‐resolving mechanisms promote abnormal NETosis , fueling autoimmunity in sickle cell disease 275
Fyn kinase is a novel modulator of erythropoietin signaling and stress erythropoiesis. 244
Peroxiredoxin 2 Plays a Pivotal Role Against Oxidation in the Early Phase of Pulmonary Artery Hypertension 236
A Selective Oral GLYT1 Inhibitor, Improves Anemia and Red Cell Survival in a Mouse Model of Beta-Thalassemia 215
New Therapeutic Options for the Treatment of Sickle Cell Disease. 190
Peroxiredoxin-2: A Novel Factor Involved in Iron Homeostasis 185
Data demonstrating the role of peroxiredoxin 2 as important anti-oxidant system in lung homeostasis. 184
Therapeutic targeting of Lyn kinase to treat chorea-acanthocytosis 173
PEROXIREDOXIN-2: A NOVEL REGULATOR OF IRON HOMEOSTASIS IN INEFFECTIVE ERYTHROPOIESIS 171
Dietary w-3 fatty acids protect against vasculopathy in a transgenic mouse model for sickle cell disease. 168
Emerging drugs in randomized controlled trials for sickle cell disease: are we on the brink of a new era in research and treatment? 166
The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a β-thalassemia mouse model 155
Dietary ω-3 fatty acid supplementation improves murine sickle cell bone disease and reprograms adipogenesis 149
Adaptative Up-Regulation of PRX2 and PRX5 Expression Characterizes Brain from a Mouse Model of Chorea-Acanthocytosis 145
Tyrosine phosphorylation modulates peroxiredoxin-2 activity in normal and diseased red cells 143
Peroxiredoxin-2 plays a pivotal role as multimodal cytoprotector in the early phase of pulmonary hypertension 141
Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in β-thalassemic mice 141
17(R)-Resolvin d1 protects against sickle cell- related inflammatory cardiomyopathy in humanized mice 140
Fyn specifically Regulates the activity of red cell glucose-6-phosphate-dehydrogenase 140
Epeleuton, a novel synthetic ω-3 fatty acid, reduces hypoxia/ reperfusion stress in a mouse model of sickle cell disease 139
The Novel Role That Nrf2 Plays in Erythropoiesis during Aging 139
Duality of Nrf2 in iron-overload cardiomyopathy 135
Resolvin D1 and Resolvin D2 Protect Against Hypoxia/Reoxygenation Induced Lung and Kidney Damage in a Sickle Cell Mouse Model of Acute Vaso-Occlusive Crisis 135
Bitopertin, a selective oral GLYT1 inhibitor, improves anemia in a mouse model of β-thalassemia 135
Resolution of sickle cell disease-associated inflammation and tissue damage with 17R-resolvin D1. 133
An Oral Carbon Monoxide-Releasing Molecule Protects against Acute Hyper-hemolysis in Sickle Cell Disease 128
Nrf2 Plays a Key Role in Erythropoiesis during Aging 115
Oxidation Impacts the Intracellular Signaling Machinery in Hematological Disorders 112
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease 108
In humanized sickle cell mice, imatinib protects against sickle cell-related injury 104
Erythrocyte pyruvate kinase activation in red cell disorders. 101
Plasma peroxiredoxin changes and inflammatory cytokines support the involvement of neuro-inflammation and oxidative stress in Autism Spectrum Disorder 91
Targeting lyn kinase in chorea-acanthocytosis: A translational treatment approach in a rare disease 90
Premature skeletal muscle aging in VPS13A deficiency relates to impaired autophagy 88
Treatment with recombinant ADAMTS13, alleviates hypoxia/reoxygenation-induced pathologies in a mouse model of human sickle cell disease 69
Exercise reveals precocious-subclinical cardiovascular and muscular dysfunction in transfusion dependent beta-thalassemia (TDT) patients without cardiac iron overload 5
Totale 5.188
Categoria #
all - tutte 17.067
article - articoli 14.343
book - libri 0
conference - conferenze 2.185
curatela - curatele 0
other - altro 539
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.134


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022195 0 60 9 10 14 6 9 12 18 4 10 43
2022/2023495 26 71 43 67 31 118 0 18 41 51 18 11
2023/2024411 12 21 30 49 41 42 19 27 3 22 117 28
2024/2025915 49 40 42 143 41 64 69 43 143 62 75 144
2025/20262.529 166 100 159 380 701 159 230 136 207 159 87 45
2026/202791 66 25 0 0 0 0 0 0 0 0 0 0
Totale 5.188